The Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, University of Manitoba, Centre Rm. 3016, 351 TachéAvenue, Winnipeg, Manitoba, Canada R2H 2A6; Department of Physiology, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
The Institute of Cardiovascular Sciences, St. Boniface Hospital Research Centre, University of Manitoba, Centre Rm. 3016, 351 TachéAvenue, Winnipeg, Manitoba, Canada R2H 2A6; Department of Physiology, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada; Department of Pharmacology and Therapeutics, College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.
Trends Cardiovasc Med. 2014 Nov;24(8):325-31. doi: 10.1016/j.tcm.2014.08.002. Epub 2014 Aug 13.
To date, one of the most intriguing and compelling concepts to impact contemporary cell biology is the notion that cell fate is "programmed" or genetically controlled. Indeed, the regulation of cell fate is crucial for embryonic development, and tissue homeostasis. Given the importance of removing damaged or irreversibly injured cells from the body, it is not surprising that defects in the regulatory mechanisms that govern cell death and/or survival more generally have been implicated in a number of human pathologies including cancer, neurodegenerative diseases, and cardiac failure. Several processes involved in the regulation of cell fate through apoptosis, necrosis, and autophagy are commonly linked through the actions of certain Bcl-2 proteins that act on the mitochondrion. For example, the Bcl-2 protein Beclin-1 is actively involved in the clearance of damaged mitochondria via mitophagy, while other Bcl-2 proteins such as Bax/Bak can initiate apoptosis or necrotic signaling pathways. The overlapping and redundant nature of these proteins highlights their evolutionary importance for regulating cardiac cell survival and death during normal and disease states. Here, we explore the interrelationship between these signaling pathways and the cellular effectors that influence cardiac cell fate.
迄今为止,最能引起当代细胞生物学兴趣并具有强大影响力的概念之一是,细胞命运是“编程”或受基因控制的。事实上,细胞命运的调控对于胚胎发育和组织稳态至关重要。鉴于从体内清除受损或不可逆损伤的细胞至关重要,因此,调控细胞死亡和/或存活的调节机制缺陷与包括癌症、神经退行性疾病和心力衰竭在内的许多人类病理有关,这并不奇怪。通过细胞凋亡、坏死和自噬来调节细胞命运的几个过程通常通过作用于线粒体的某些 Bcl-2 蛋白的作用而联系在一起。例如,Bcl-2 蛋白 Beclin-1 通过线粒体自噬积极参与清除受损的线粒体,而 Bax/Bak 等其他 Bcl-2 蛋白可以启动细胞凋亡或坏死信号通路。这些蛋白质的重叠和冗余性质突出了它们在调节心脏细胞在正常和疾病状态下的存活和死亡方面的进化重要性。在这里,我们探讨了这些信号通路与影响心脏细胞命运的细胞效应物之间的相互关系。